Drug factory · FDA FEI 3004983316

Pharma Mar S.A.

Avenida de los Reyes 1, Pol. Ind. La Mina, Colmenar Viejo, Spain

Spain: 1

Problems found, fixed voluntarily at FDA's last inspection, Jan 26, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

4 drug inspections on record since 2009: 1 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
LurbinectedinMakes the active ingredient Jazz Pharmaceuticals, Inc. 68727-712
TrabectedinMakes the active ingredient Janssen Products LP 59676-610

FDA inspection history

EndedResultProgramProblems noted
Jan 26, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 21, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 24, 2015Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 30, 2009No problems foundDrug Quality Assurance—

Registered with FDA for: api manufacture.